
Josh Schoeller, LexisNexis Risk Solutions
Advertisement
Articles by Josh Schoeller, LexisNexis Risk Solutions

Advertisement
Latest Updated Articles
The next generation of MDMPublished: October 29th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
What MFN Pricing Means for Future Drug Development
3
Pharma Pulse: New CDER Director Appointed, as Medicaid Shows Potential to Save Cancer Lives
4
